ABAXIS Company Profile (NASDAQ:ABAX)

About ABAXIS (NASDAQ:ABAX)

ABAXIS logoAbaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ABAX
  • CUSIP: 00256710
  • Web: www.abaxis.com
Capitalization:
  • Market Cap: $1.16 billion
  • Outstanding Shares: 22,653,000
Average Prices:
  • 50 Day Moving Avg: $51.95
  • 200 Day Moving Avg: $49.61
  • 52 Week Range: $44.12 - $55.95
P/E:
  • Trailing P/E Ratio: 35.67
  • Foreward P/E Ratio: 35.60
  • P/E Growth: 6.71
Sales & Book Value:
  • Annual Revenue: $227.22 million
  • Price / Sales: 5.11
  • Book Value: $11.81 per share
  • Price / Book: 4.34
Dividend:
  • Annual Dividend: $0.56
  • Dividend Yield: 1.1%
Profitability:
  • EBIDTA: $51.83 million
  • Net Margins: 14.40%
  • Return on Equity: 11.37%
  • Return on Assets: 9.95%
Debt:
  • Current Ratio: 6.97%
  • Quick Ratio: 5.81%
Misc:
  • Average Volume: 112,692 shs.
  • Beta: 0.84
  • Short Ratio: 18.92
 
Frequently Asked Questions for ABAXIS (NASDAQ:ABAX)

What is ABAXIS's stock symbol?

ABAXIS trades on the NASDAQ under the ticker symbol "ABAX."

How often does ABAXIS pay dividends? What is the dividend yield for ABAXIS?

ABAXIS announced a quarterly dividend on Thursday, April 27th. Shareholders of record on Thursday, June 1st will be given a dividend of $0.14 per share on Thursday, June 15th. This represents a $0.56 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date is Tuesday, May 30th. View ABAXIS's Dividend History.

How were ABAXIS's earnings last quarter?

ABAXIS, Inc. (NASDAQ:ABAX) issued its quarterly earnings results on Tuesday, October, 25th. The company reported $0.34 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.35 by $0.01. The firm earned $58.60 million during the quarter, compared to analysts' expectations of $60.69 million. ABAXIS had a net margin of 14.40% and a return on equity of 11.37%. ABAXIS's quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.34 earnings per share. View ABAXIS's Earnings History.

When will ABAXIS make its next earnings announcement?

ABAXIS is scheduled to release their next quarterly earnings announcement on Thursday, July, 27th 2017. View Earnings Estimates for ABAXIS.

Where is ABAXIS's stock going? Where will ABAXIS's stock price be in 2017?

6 brokerages have issued 1 year price objectives for ABAXIS's shares. Their predictions range from $39.00 to $56.50. On average, they expect ABAXIS's share price to reach $47.88 in the next year. View Analyst Ratings for ABAXIS.

Who are some of ABAXIS's key competitors?

Who are ABAXIS's key executives?

ABAXIS's management team includes the folowing people:

  • Clinton H. Severson, Chairman of the Board, Chief Executive Officer
  • Donald Peter Wood, President, Chief Operating Officer
  • Ross Taylor, Chief Financial Officer, Vice President - Finance, Secretary
  • Kenneth P. Aron Ph.D., Chief Technology Officer
  • Craig M. Tockman, Vice President - Animal Health Sales and Marketing for North America
  • Achim Henkel, Managing Director of Abaxis Europe GmbH
  • Vernon Edward Altman, Independent Director
  • Richard J. Bastiani Ph.D., Independent Director
  • Michael D. Casey, Independent Director
  • Henk J. Evenhuis, Independent Director

Who owns ABAXIS stock?

ABAXIS's stock is owned by a number of of institutional and retail investors. Top institutional investors include Copeland Capital Management LLC (1.45%), Rockefeller Financial Services Inc. (0.85%), AMI Asset Management Corp (0.78%), Russell Investments Group Ltd. (0.49%), US Bancorp DE (0.18%) and Nisa Investment Advisors LLC (0.08%). Company insiders that own ABAXIS stock include Achim Henkel, Clinton Severson, Craig Tockman, Donald Peter Wood, Henk Evenhuis, Kenneth Aron, Prithipal Singh, Richard Bastiani and Vernon E Altman. View Institutional Ownership Trends for ABAXIS.

Who sold ABAXIS stock? Who is selling ABAXIS stock?

ABAXIS's stock was sold by a variety of institutional investors in the last quarter, including Capstone Asset Management Co.. Company insiders that have sold ABAXIS stock in the last year include Achim Henkel, Clinton Severson, Donald Peter Wood, Kenneth Aron, Prithipal Singh and Richard Bastiani. View Insider Buying and Selling for ABAXIS.

Who bought ABAXIS stock? Who is buying ABAXIS stock?

ABAXIS's stock was acquired by a variety of institutional investors in the last quarter, including Copeland Capital Management LLC, AMI Asset Management Corp, Russell Investments Group Ltd., Eqis Capital Management Inc., Rockefeller Financial Services Inc., State of Alaska Department of Revenue, US Bancorp DE and Aperio Group LLC. View Insider Buying and Selling for ABAXIS.

How do I buy ABAXIS stock?

Shares of ABAXIS can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ABAXIS's stock price today?

One share of ABAXIS stock can currently be purchased for approximately $51.26.


MarketBeat Community Rating for ABAXIS (NASDAQ ABAX)
Community Ranking:  1.4 out of 5 ()
Outperform Votes:  87 (Vote Outperform)
Underperform Votes:  214 (Vote Underperform)
Total Votes:  301
MarketBeat's community ratings are surveys of what our community members think about ABAXIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for ABAXIS (NASDAQ:ABAX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $47.88 (6.60% downside)

Analysts' Ratings History for ABAXIS (NASDAQ:ABAX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/14/2017Stifel NicolausReiterated RatingHold$48.00LowView Rating Details
6/9/2017AegisInitiated CoverageHold$56.50HighView Rating Details
2/14/2017Canaccord GenuityReiterated RatingHold$48.00N/AView Rating Details
2/1/2017Seaport Global SecuritiesUpgradeBuyN/AView Rating Details
11/30/2016Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
8/16/2016Credit Suisse GroupReiterated RatingSell$39.00N/AView Rating Details
7/22/2016Feltl & Co.DowngradeHold -> SellN/AView Rating Details
4/1/2016CL KingInitiated CoverageNeutralN/AView Rating Details
1/29/2016Piper Jaffray CompaniesLower Price TargetNeutral$49.00 -> $45.00N/AView Rating Details
10/21/2015Bank of America CorporationDowngradeNeutral -> Underperform$66.00 -> $39.00N/AView Rating Details
(Data available from 7/27/2015 forward)

Earnings

Earnings History for ABAXIS (NASDAQ:ABAX)
Earnings by Quarter for ABAXIS (NASDAQ:ABAX)
Earnings History by Quarter for ABAXIS (NASDAQ ABAX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/27/2017Q1 2018$0.33N/AView Earnings Details
4/27/2017Q4 2017$0.33$0.33$58.04 million$58.20 millionViewN/AView Earnings Details
1/26/2017Q317$0.31$0.30$54.36 million$52.80 millionViewN/AView Earnings Details
10/25/2016Q217$0.35$0.34$60.69 million$58.60 millionViewListenView Earnings Details
7/21/2016Q117$0.32$0.30$58.70 million$57.70 millionViewListenView Earnings Details
4/28/2016Q416$0.32$0.36$56.62 million$57.00 millionViewListenView Earnings Details
1/28/2016Q316$0.33$0.35$58.52 million$52.90 millionViewListenView Earnings Details
10/27/2015Q216$0.32$0.34$56.20 million$56.00 millionViewListenView Earnings Details
7/23/2015Q116$0.28$0.31$53.75 million$53.10 millionViewListenView Earnings Details
4/30/2015Q415$0.27$0.17$55.62 million$52.00 millionViewN/AView Earnings Details
1/29/2015Q315$0.25$0.26$51.70 million$59.50 millionViewN/AView Earnings Details
10/21/2014Q215$0.23$0.24$50.55 million$53.90 millionViewListenView Earnings Details
7/24/2014Q115$0.19$0.21$46.95 million$47.50 millionViewN/AView Earnings Details
4/24/2014Q414$0.19$0.17$45.74 million$42.04 millionViewN/AView Earnings Details
1/31/2014Q314$0.20$0.14$49.47 million$40.00 millionViewN/AView Earnings Details
10/22/2013Q114$0.21$0.18$48.60 million$45.90 millionViewN/AView Earnings Details
7/25/2013Q1 2014$0.23$0.14$49.13 million$43.20 millionViewListenView Earnings Details
4/25/2013Q4 2013$0.26$0.30$52.47 million$50.00 millionViewListenView Earnings Details
1/31/2013Q3 2013$0.20$0.22$45.75 million$49.80 millionViewListenView Earnings Details
10/23/2012$0.18$0.18ViewN/AView Earnings Details
7/26/2012$0.17$0.13ViewN/AView Earnings Details
4/26/2012$0.16$0.21ViewN/AView Earnings Details
1/26/2012$0.16$0.13ViewN/AView Earnings Details
10/25/2011$0.14$0.15ViewN/AView Earnings Details
7/28/2011$0.16$0.10ViewN/AView Earnings Details
4/28/2011$0.16$0.15ViewN/AView Earnings Details
1/27/2011$0.18$0.17ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ABAXIS (NASDAQ:ABAX)
2017 EPS Consensus Estimate: $1.29
2018 EPS Consensus Estimate: $1.39
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.34$0.34$0.34
Q2 20171$0.34$0.34$0.34
Q3 20172$0.29$0.32$0.31
Q4 20172$0.27$0.33$0.30
Q1 20181$0.33$0.33$0.33
Q2 20181$0.38$0.38$0.38
Q3 20181$0.31$0.31$0.31
Q4 20181$0.37$0.37$0.37
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for ABAXIS (NASDAQ:ABAX)
Most Recent Dividend:6/15/2017
Annual Dividend:$0.56
Dividend Yield:1.09%
Payout Ratio:39.16% (Trailing 12 Months of Earnings)
45.90% (Based on This Year's Estimates)
38.89% (Based on Next Year's Estimates)
Dividend Payments by Quarter for ABAXIS (NASDAQ:ABAX)

Dividend History by Quarter for ABAXIS (NASDAQ ABAX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/27/2017quarterly$0.141.24%5/30/20176/1/20176/15/2017
1/26/2017quarterly$0.141.13%2/27/20173/1/20173/15/2017
10/28/2016quarterly$0.141.17%11/29/201612/1/201612/15/2016
7/21/2016quarterly$0.121.04%8/30/20169/1/20169/15/2016
4/28/2016quarterly$0.121.06%6/1/20166/3/20166/17/2016
1/28/2016quarterly$0.111.01%3/1/20163/3/20163/17/2016
11/3/2015quarterly$0.110.84%12/1/201512/3/201512/17/2015
7/23/2015quarterly$0.110.9%9/1/20159/3/20159/17/2015
4/30/2015quarterly$0.110.79%6/2/20156/4/20156/18/2015
1/30/2015quarterly$0.100.65%2/27/20153/3/20153/17/2015
10/23/2014quarterly$0.100.82%11/13/201411/17/201412/16/2014
7/24/2014quarterly$0.100.86%8/29/20149/3/20149/17/2014
4/24/2014quarterly$0.105/30/20146/3/20146/17/2014
12/6/2012special$1.0012/13/201212/17/201212/28/2012
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for ABAXIS (NASDAQ:ABAX)
Insider Ownership Percentage: 4.10%
Institutional Ownership Percentage: 98.34%
Insider Trades by Quarter for ABAXIS (NASDAQ:ABAX)
Institutional Ownership by Quarter for ABAXIS (NASDAQ:ABAX)
Insider Trades by Quarter for ABAXIS (NASDAQ:ABAX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2017Achim HenkelInsiderSell650$48.87$31,765.50View SEC Filing  
5/8/2017Achim HenkelDirectorSell8,650$47.75$413,037.50View SEC Filing  
2/2/2017Richard BastianiDirectorSell4,000$51.12$204,480.00View SEC Filing  
12/6/2016Clinton SeversonCEOSell15,000$51.35$770,250.00View SEC Filing  
12/2/2016Kenneth AronInsiderSell5,000$51.09$255,450.00View SEC Filing  
9/9/2016Clinton SeversonCEOSell2,000$48.29$96,580.00View SEC Filing  
9/8/2016Prithipal SinghDirectorSell1,000$49.50$49,500.00View SEC Filing  
8/25/2016Prithipal SinghDirectorSell1,500$50.30$75,450.00View SEC Filing  
8/24/2016Donald Peter WoodInsiderSell8,500$50.21$426,785.00View SEC Filing  
6/9/2016Richard BastianiDirectorSell5,000$46.75$233,750.00View SEC Filing  
5/17/2016Achim HenkelDirectorSell5,000$44.43$222,150.00View SEC Filing  
5/9/2016Henk EvenhuisDirectorSell3,000$45.00$135,000.00View SEC Filing  
2/9/2016Vernon E AltmanDirectorBuy303$39.87$12,080.61View SEC Filing  
12/8/2015Craig TockmanVPSell560$54.44$30,486.40View SEC Filing  
2/9/2015Prithipal SinghDirectorSell2,500$60.50$151,250.00View SEC Filing  
12/8/2014Kenneth AronCTOSell2,000$56.68$113,360.00View SEC Filing  
11/25/2014Clinton SeversonCEOSell2,286$56.00$128,016.00View SEC Filing  
11/13/2014Clinton SeversonCEOSell10,000$55.00$550,000.00View SEC Filing  
11/5/2014Clinton SeversonCEOSell10,000$54.00$540,000.00View SEC Filing  
11/3/2014Alberto Santa InesCFOSell1,652$53.09$87,704.68View SEC Filing  
11/3/2014Clinton SeversonCEOSell5,000$53.00$265,000.00View SEC Filing  
10/31/2014Clinton SeversonCEOSell10,000$51.50$515,000.00View SEC Filing  
8/12/2014Richard BastianiDirectorSell1,000$45.40$45,400.00View SEC Filing  
7/30/2014Alberto Santa InesCFOSell10,738$47.81$513,383.78View SEC Filing  
7/29/2014Alberto Santa InesCFOSell17,293$48.01$830,236.93View SEC Filing  
6/5/2014Richard BastianiDirectorSell2,000$42.10$84,200.00View SEC Filing  
6/3/2014Richard BastianiDirectorSell4,000$41.88$167,520.00View SEC Filing  
5/22/2014Achim HenkelDirectorSell8,500$41.63$353,855.00View SEC Filing  
5/14/2014Henk EvenhuisDirectorSell4,000$44.06$176,240.00View SEC Filing  
5/1/2014Henk EvenhuisDirectorSell4,500$41.00$184,500.00View SEC Filing  
3/4/2014Vladimir OstoichVPSell9,800$38.53$377,594.00View SEC Filing  
2/24/2014Kenneth AronCTOSell1,000$38.98$38,980.00View SEC Filing  
2/13/2014Donald Peter WoodCOOSell8,864$38.50$341,264.00View SEC Filing  
6/7/2013Clinton SeversonCEOSell10,000$44.50$445,000.00View SEC Filing  
6/7/2013Martin MulroyInsiderSell14,000$44.80$627,200.00View SEC Filing  
5/22/2013Kenneth AronCTOSell4,200$43.28$181,776.00View SEC Filing  
5/7/2013Achim HenkelDirectorSell5,000$44.07$220,350.00View SEC Filing  
3/1/2013Achim HenkelDirectorSell1,000$42.85$42,850.00View SEC Filing  
2/26/2013Martin MulroyInsiderSell12,000$41.84$502,080.00View SEC Filing  
2/5/2013Kenneth AronCTOSell40,000$44.13$1,765,200.00View SEC Filing  
2/4/2013Martin MulroyInsiderSell12,000$43.97$527,640.00View SEC Filing  
11/23/2012Richard BastianiDirectorSell5,000$36.60$183,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for ABAXIS (NASDAQ:ABAX)
Latest Headlines for ABAXIS (NASDAQ:ABAX)
Source:
DateHeadline
americanbankingnews.com logoHead to Head Survey: Cogentix Medical (CGNT) vs. ABAXIS (ABAX)
www.americanbankingnews.com - July 26 at 8:54 AM
finance.yahoo.com logoABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : July 21, 2017
finance.yahoo.com - July 21 at 4:27 PM
americanbankingnews.com logoZacks: Brokerages Expect ABAXIS, Inc. (NASDAQ:ABAX) to Post $0.32 EPS
www.americanbankingnews.com - July 21 at 12:28 PM
bizjournals.com logoVeterinary Chemistry Analyzer Market by Product Application & Animal - Global Forecast to 2022
www.bizjournals.com - July 21 at 1:27 AM
americanbankingnews.com logoABAXIS, Inc. (NASDAQ:ABAX) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - July 20 at 7:51 AM
finance.yahoo.com logoMedical Product Stocks' Earnings on Jul 20: ABT, ISRG & More
finance.yahoo.com - July 19 at 3:20 PM
prnewswire.com logoAbaxis To Report First Quarter Fiscal Year 2018 Financial Results On Thursday ...
www.prnewswire.com - July 18 at 3:21 PM
finance.yahoo.com logoAbaxis To Report First Quarter Fiscal Year 2018 Financial Results On Thursday, July 27, 2017
finance.yahoo.com - July 18 at 3:21 PM
americanbankingnews.com logoABAXIS, Inc. (ABAX) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 17 at 7:30 AM
americanbankingnews.com logoABAXIS, Inc. (NASDAQ:ABAX) Given Hold Rating at Stifel Nicolaus
www.americanbankingnews.com - July 15 at 11:18 AM
americanbankingnews.com logoCritical Comparison: ABAXIS (ABAX) vs. Accelerate Diagnostics (AXDX)
www.americanbankingnews.com - July 14 at 2:32 PM
finance.yahoo.com logoETFs with exposure to ABAXIS, Inc. : July 11, 2017
finance.yahoo.com - July 11 at 4:19 PM
americanbankingnews.com logoABAXIS, Inc. (ABAX) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - July 11 at 12:41 AM
americanbankingnews.com logoABAXIS, Inc. (ABAX) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - July 2 at 12:02 PM
finance.yahoo.com logoAbaxis (ABAX) Product Portfolio Strong, Competition Rife
finance.yahoo.com - June 30 at 3:24 PM
finance.yahoo.com logoETFs with exposure to ABAXIS, Inc. : June 29, 2017
finance.yahoo.com - June 29 at 3:20 PM
americanbankingnews.com logoZacks: Brokerages Anticipate ABAXIS, Inc. (ABAX) Will Post Quarterly Sales of $60.62 Million
www.americanbankingnews.com - June 29 at 11:40 AM
americanbankingnews.com logo Analysts Anticipate ABAXIS, Inc. (ABAX) to Post $0.32 Earnings Per Share
www.americanbankingnews.com - June 27 at 10:08 AM
finance.yahoo.com logoABAXIS, Inc. :ABAX-US: Earnings Analysis: Q4, 2017 By the Numbers : June 19, 2017
finance.yahoo.com - June 19 at 3:15 PM
americanbankingnews.com logoThermo Fisher Scientific (TMO) and ABAXIS (ABAX) Financial Review
www.americanbankingnews.com - June 17 at 10:44 AM
americanbankingnews.com logoABAXIS, Inc. (ABAX) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - June 16 at 7:56 PM
americanbankingnews.com logoAegis Initiates Coverage on Abaxis Inc (ABAX)
www.americanbankingnews.com - June 9 at 7:56 AM
finance.yahoo.com logoETFs with exposure to ABAXIS, Inc. : June 6, 2017
finance.yahoo.com - June 6 at 3:19 PM
finance.yahoo.com logoABAXIS, Inc. :ABAX-US: Earnings Analysis: 2017 By the Numbers : June 5, 2017
finance.yahoo.com - June 5 at 12:59 PM
americanbankingnews.com logo$60.62 Million in Sales Expected for Abaxis Inc (ABAX) This Quarter
www.americanbankingnews.com - June 3 at 9:48 AM
marketwatch.com logoVeterinary Chemistry Analyzer Market Worth 1,205.2 Million USD by 2022
www.marketwatch.com - June 1 at 3:19 PM
americanbankingnews.com logoAbaxis Inc (ABAX) Expected to Announce Earnings of $0.32 Per Share
www.americanbankingnews.com - June 1 at 8:10 AM
americanbankingnews.com logoAbaxis Inc (ABAX) Insider Sells $31,765.50 in Stock
www.americanbankingnews.com - May 31 at 8:36 PM
finance.yahoo.com logoAbaxis, Inc. to Present at the Stifel 2017 Dental & Veterinary Conference and Jefferies 2017 Global Healthcare Conference
finance.yahoo.com - May 25 at 3:22 PM
americanbankingnews.com logoAbaxis Inc (ABAX) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - May 19 at 10:48 PM
finance.yahoo.com logoABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : May 15, 2017
finance.yahoo.com - May 15 at 3:16 PM
americanbankingnews.com logoAchim Henkel Sells 8,650 Shares of Abaxis Inc (ABAX) Stock
www.americanbankingnews.com - May 10 at 11:22 PM
americanbankingnews.com logoZacks: Analysts Expect Abaxis Inc (ABAX) to Post $0.32 EPS
www.americanbankingnews.com - May 8 at 10:30 AM
streetinsider.com logoForm 4 ABAXIS INC For: May 01 Filed by: TOCKMAN CRAIG
www.streetinsider.com - May 5 at 3:15 PM
americanbankingnews.com logoAbaxis (ABAX) Earning Somewhat Positive Media Coverage, Analysis Finds
www.americanbankingnews.com - May 2 at 7:46 AM
americanbankingnews.com logoAbaxis Inc (ABAX) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - May 1 at 11:06 PM
finance.yahoo.com logoABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : May 1, 2017
finance.yahoo.com - May 1 at 11:59 AM
americanbankingnews.com logoAbaxis (ABAX) Earning Somewhat Positive Press Coverage, Analysis Finds
www.americanbankingnews.com - April 29 at 8:40 AM
finance.yahoo.com logoEdited Transcript of ABAX earnings conference call or presentation 27-Apr-17 8:15pm GMT
finance.yahoo.com - April 28 at 3:05 PM
finance.yahoo.com logoAbaxis (ABAX) Beats Q4 Earnings Estimates, Revenues In Line
finance.yahoo.com - April 28 at 3:05 PM
americanbankingnews.com logoAbaxis Inc (ABAX) Posts Earnings Results, Hits Estimates
www.americanbankingnews.com - April 27 at 10:26 PM
americanbankingnews.com logoAbaxis Inc (ABAX) Declares Quarterly Dividend of $0.14
www.americanbankingnews.com - April 27 at 10:16 PM
nasdaq.com logoAbaxis Inc. Reveals 9% Drop In Q4 Profit
www.nasdaq.com - April 27 at 8:34 PM
finance.yahoo.com logoAbaxis Reports Financial Performance for the Fourth Quarter and Fiscal 2017 and Declares Quarterly Cash Dividend
finance.yahoo.com - April 27 at 8:34 PM
finance.yahoo.com logoAbaxis tops 4Q profit forecasts
finance.yahoo.com - April 27 at 8:34 PM
americanbankingnews.com logoAbaxis (ABAX) Receives News Impact Rating of 0.16
www.americanbankingnews.com - April 26 at 9:15 AM
americanbankingnews.com logoAbaxis Inc (ABAX) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - April 25 at 12:53 AM
finance.yahoo.com logoABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : April 24, 2017
finance.yahoo.com - April 24 at 3:16 PM
finance.yahoo.com logoABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : April 21, 2017
finance.yahoo.com - April 21 at 3:08 PM
finance.yahoo.com logoVeterinary Diagnostics Market by Product (Instruments and Consumables), Technology (Clinical Biochemistry, …
finance.yahoo.com - April 21 at 1:51 AM

Social

Chart

ABAXIS (ABAX) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by MarketBeat.com Staff